Nuvectis Pharma Balance Sheet (2021-2026) | NVCT

Balance Sheet Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
5.74M16.70M13.57M23.64M15.50M24.60M22.10M19.46M18.12M17.17M29.90M26.79M35.44M31.63M25.10M
Prepaid Assets (Quarter)
0.09M0.93M0.67M1.23M0.41M0.74M0.34M0.20M0.06M0.25M0.18M0.14M0.07M0.28M0.21M0.14M0.07M0.27M
Current Assets (Quarter)
5.83M17.62M14.24M24.87M20.41M16.21M24.94M22.26M19.18M19.71M18.30M17.31M18.61M30.15M27.01M35.59M31.71M25.40M
Non-Current Assets
Non-Current Assets (Quarter)
0.82M
Assets (Quarter)
6.66M17.62M14.24M24.87M20.41M16.21M24.94M22.26M19.18M19.71M18.30M17.31M18.61M30.15M27.01M35.59M31.71M25.40M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.06M1.35M1.43M2.25M2.91M2.10M1.80M3.49M2.77M1.76M1.85M2.26M2.50M2.99M4.98M6.44M6.27M4.70M
Payables (Quarter)
1.06M1.35M1.43M2.25M2.91M2.10M1.80M3.49M2.77M1.76M1.85M2.26M2.50M2.99M4.98M6.44M6.27M4.70M
Accumulated Expenses (Quarter)
0.14M0.09M0.79M0.86M2.38M0.16M0.40M0.16M0.41M0.49M0.31M0.28M5.56M0.86M5.08M0.07M6.91M6.45M
Total Current Liabilities (Quarter)
2.42M3.06M2.74M4.49M6.19M3.93M4.61M5.58M6.98M5.69M5.77M6.32M8.89M9.19M10.13M11.58M13.30M11.18M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
0.82M
Preferred Stock Liabilities (Quarter)
11.22M15.25M15.25M
Total Liabilities (Quarter)
4.40M8.93M2.42M3.06M2.74M4.49M6.19M3.93M4.61M5.58M6.98M5.69M5.77M6.32M8.89M9.19M10.13M11.58M13.30M11.18M
Shareholder's Equity
Common Equity (Quarter)
-4.40M-8.93M-11.01M14.56M11.50M20.37M14.22M12.27M20.33M16.69M12.20M14.02M12.53M10.99M9.71M20.95M16.87M24.01M18.41M14.22M
Shareholder's Equity (Quarter)
-4.40M-8.93M-11.01M14.56M11.50M20.37M14.22M12.27M20.33M16.69M12.20M14.02M12.53M10.99M9.71M20.95M16.87M24.01M18.41M14.22M
Liabilities and Shareholders Equity (Quarter)
6.66M17.62M14.24M24.87M20.41M16.21M24.94M22.26M19.18M19.71M18.30M17.31M18.61M30.15M27.01M35.59M31.71M25.40M
Retained Earnings (Quarter)
-12.90M-15.84M-19.40M-25.30M-31.98M-36.00M-41.70M-47.60M-54.24M-58.40M-62.80M-67.00M-73.25M-78.60M-84.90M-92.40M-99.69M-105.70M
Treasury Shares (Quarter)
0.94M1.39M1.40M1.37M2.11M2.20M2.24M2.23M2.88M
Shares Outstanding (Quarter)
4.51M4.51M4.75M12.72M12.72M14.64M15.19M15.89M17.22M17.31M17.42M18.36M18.75M18.99M19.50M23.63M23.88M25.64M25.68M26.53M